ENDPQ — Endo International Share News
0.000.00%
Last trade - 00:00- $0.14m
- $7.37bn
- $2.01bn
Brief: Endo Acquires Six Development-Stage, Ready-To-Use Injectable Product Candidates From Nevakar
Brief: Press Release - Nevakar Injectables Sells Six Development-Stage, Ready-To-Use Injectable Product Candidates To Endo Ventures Limited
Brief: Endo Says Will No Longer Exclude Acquired In-Process R&D Charges From Non-GAAP Performance Measures
Brief: Nevakar Injectables Receives U.S. FDA Approval Of Ready-To-Use Ephedrine Injection
Brief: Tennessee Court Of Appeals Orders Recusal Of Trial Court Judge And Vacates Default Judgment On Liability Against Endo
Alabama reaches $276 mln opioid settlement with J&J, McKesson, Endo -attorney general (updated)
Alabama settles opioid claims against J&J, distributors for $276 mln - attorney general
Walgreens fed opioid addiction, Florida says as trial starts (updated)
Walgreens trial over its part in Florida opioid crisis set to begin
West Virginia faces off against J&J, drugmakers at trial over opioid epidemic
Florida reaches $878 million opioid settlements with CVS, Teva, others (updated)
Florida reaches $878 mln opioid settlements with CVS, Teva, others
Brief: Endo Begins Shipment Of Premixed Ephedrine Sulfate Injection In Ready-To-Use Vials
Texas demands drug companies turn over documents on 'puberty blocking' drugs for children
U.S. RESEARCH ROUNDUP- Autozone, Domino's Pizza, Salesforce.com
Endo International PLC reports results for the quarter ended in December - Earnings Summary
Brief: Endo Reports Fourth-Quarter And Full-Year 2021 Financial Results
Endo International PLC expected to post earnings of 67 cents a share - Earnings Preview
Brief: Endo Announces Launch Of Ready-To-Use Vasostrict In Pre-Mix Bottles